Pfizer
Corporate/Government Newsroom
Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives. We make medicines and vaccines that help people when they are sick and prevent them from getting sick in the first place, as well as some of the world’s best-known consumer healthcare brands. Every day, our colleagues work in developed and emerging markets to treat, cure and eradicate life-threatening conditions and challenge some of the most feared diseases of our time. Pfizer also collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more, visit www.pfizer.com. Source
Actions
Media Outlet details
| Scope | International |
|---|---|
| Language | English |
| Country | United States of America |
Similarweb UVM
|
Request pricing |
Comscore UVM
|
Request pricing |
Recent Articles
Search ArticlesA Return to Munich: Reflecting on Eight Years of Progress in ATTR-CM
Compared with historic, pre-treatment-era populations of patients with ATTR-CM, in the past eight years we have seen substantially lower mortality rates, reduced hospitalizations, and better preservation of quality of life and functional capacity.3,4 These improvements in outcomes for people living with ATTR-CM have been a direct result of sustained work across the cardiology community.
The Hidden Infrastructure Behind Every Pfizer Medicine
Getting a medication can seem as simple as a trip to the pharmacy. In reality, that moment is the last step in a complex, rigorous, and largely invisible process. Behind every dose, an extraordinarily complex manufacturing operation helps produce medicines consistently, regardless of where they’re made or where they’ll be used.
Decoding Tumors: Inside the Spatial Revolution in Cancer Research
Cancer emerges from the very same cellular machinery that keeps us alive. It puzzles both pathologists and the immune system because tumors, unlike infections, share the basic structures and behavioral blueprints of healthy, normal tissue, a resemblance that can let them slip past immune surveillance undetected.
Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for PF-07307405, the companies’ 6-valent outer surface protein A (OspA)-based Lyme disease vaccine candidate and will begin its assessment of the application.
Direct Relief and The Pfizer Foundation Expand Support for Community Health Centers on the Front Lines of Infectious Disease Care
Credit: Direct Relief This spring, Direct Relief and The Pfizer Foundation announced the third cohort of the Innovation Awards in Community Health, marking five years of support for community health centers working to strengthen infectious disease prevention, education, screening, testing, treatment, and care in medically underserved communities.
How Pfizer Thinks About AI
At Pfizer, our ambition is to be the most AI-forward company in our industry, and we are making great progress every day. I spend more time thinking about it than almost anything else because I believe this is an unprecedented opportunity. AI will fundamentally improve how we discover medicines, how we develop and manufacture them and how quickly we reach patients. Very few technologies can change every corner of a business in this way.
Beyond the Breakthrough: The Manufacturing Work That Gets Medicines and Vaccines to Patients
Scientific discoveries form the basis of every medical breakthrough. But transforming those discoveries into medicines that reach patients requires another kind of innovation: manufacturing. Behind every dose, a complex global network of manufacturing sites, supply chain experts, quality teams, and logistics specialists work together to produce medicines consistently, reliably, and at the scale patients need.
July Social Media Round-Up—America 250, Pfizer Futures, and More
Even amidst the cookouts, fireworks, and vacations, Pfizer remains hard at work all summer long, and July was no different. Last month, we held important conversations around living with alopecia areata, shared the story of a Pfizer colleague and cancer survivor, and reflected on the changes in science over the years. CEO Albert Bourla celebrated America’s 250th birthday, shared advice for our outgoing Pfizer Futures class, and congratulated the World Cup winners.
Exploring the Latest Advances in Menstrual Migraine Research
For millions of people who menstruate, migraine attacks don’t always strike at random. For many, they’re more likely to occur in and around the days of the menstrual period, driven in part by the hormonal shifts of the cycle. When migraine attacks consistently occur on or around menstruation, the pattern has a name—menstrual migraine—and it’s more than just a bad headache.